Cetera Investment Advisers
MIST icon

Cetera Investment Advisers’s Milestone Pharmaceuticals MIST Stock Holding History

Cetera Investment Advisers’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5K Sell
14,704
-6,018
-29% -$10.5K ﹤0.01% 4667
2025
Q4 		$41.9K Buy
+20,722
New +$44.6K ﹤0.01% 4525
2025
Q1 		– Sell
-24,731
Closed -$58.4K – 4034
2024
Q4 		$58.4K Buy
24,731
+60
+0.2% +$103 ﹤0.01% 3646
2024
Q3 		$37.5K Buy
24,671
+3,982
+19% +$5.79K ﹤0.01% 3618
2024
Q2 		$27.3K Buy
20,689
+3,262
+19% +$5.24K ﹤0.01% 3631
2024
Q1 		$31.2K Buy
+17,427
New +$28.3K ﹤0.01% 3609

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Cetera Investment Advisers's MIST Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Milestone Pharmaceuticals (MIST) stake by 29% in Q1 2026, selling an estimated $10.5K and leaving 14,704 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4667.

Cetera Investment Advisers first reported a position in MIST in Q1 2024 and has held it in 6 quarters since. The position peaked at $58.4K in Q4 2024. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Cetera Investment Advisers held 14,704 shares of Milestone Pharmaceuticals worth $17.5K as of Q1 2026.
  • Cetera Investment Advisers sold 6,018 Milestone Pharmaceuticals shares in Q1 2026, an estimated $10.5K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4667 holding.
  • Cetera Investment Advisers first reported a position in Milestone Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Milestone Pharmaceuticals position peaked at $58.4K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.